Exceptional Response of <scp>HER2</scp> ‐Positive Breast Cancer to Osimertinib: A Case Report

Hirotoshi Yasui, Misaki Hatasa, Ko Ohara, Kaito Sano, Yasutaka Mori, Tomofumi Shibata, Yasutaka Fukui, Mitsuru Odate, Yoshifumi Arai, Masahiro Fujii, Yasushi Makino

Open source

DOI: 10.1111/1759-7714.70379
Published: 2026-08
Container: Thoracic Cancer
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/1759-7714.70379,
  title = {Exceptional Response of
                    <scp>HER2</scp>
                    ‐Positive Breast Cancer to Osimertinib: A Case Report},
  author = {Hirotoshi Yasui and Misaki Hatasa and Ko Ohara and Kaito Sano and Yasutaka Mori and Tomofumi Shibata and Yasutaka Fukui and Mitsuru Odate and Yoshifumi Arai and Masahiro Fujii and Yasushi Makino},
  year = {2026},
  journal = {Thoracic Cancer},
  doi = {10.1111/1759-7714.70379},
  url = {https://doi.org/10.1111/1759-7714.70379}
}

RIS

TY  - JOUR
TI  - Exceptional Response of
                    <scp>HER2</scp>
                    ‐Positive Breast Cancer to Osimertinib: A Case Report
AU  - Hirotoshi Yasui
AU  - Misaki Hatasa
AU  - Ko Ohara
AU  - Kaito Sano
AU  - Yasutaka Mori
AU  - Tomofumi Shibata
AU  - Yasutaka Fukui
AU  - Mitsuru Odate
AU  - Yoshifumi Arai
AU  - Masahiro Fujii
AU  - Yasushi Makino
PY  - 2026
JO  - Thoracic Cancer
DO  - 10.1111/1759-7714.70379
UR  - https://doi.org/10.1111/1759-7714.70379
ER  -

APA

Yasui, H., Hatasa, M., Ohara, K., Sano, K., Mori, Y., Shibata, T., Fukui, Y., Odate, M., Arai, Y., Fujii, M., & Makino, Y. (2026). Exceptional Response of <scp>HER2</scp> ‐Positive Breast Cancer to Osimertinib: A Case Report. Thoracic Cancer. https://doi.org/10.1111/1759-7714.70379

Source records

crossref · retrieved 2026-09-26T18:44:33.551Z